The Tata group is reviewing its seven year-old investment in closely-held research and development company Advinus Therapeutics, according to three people familiar with the development. The group is open to the idea of attracting strategic investors into the company and accepting significant equity dilution at the right valuation, these people said. "They are looking to … Continue reading Seven year itch? Tata group reviews investment in Advinus Therapeutics
Apothecurry 